MELTZER LESLIE (Chief Research and Development) received a stock award from APELLIS PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/30/2026ACC: 0001492422-26-000075
Officer· Chief Research and Development
Since Jan 2026
+45.22K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
45.22K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+45.22K
Price / share
—
Trade value
—
% of position
73.2%
1/28/2026
61.80K→107.02K
Total
Net shares
+45.22K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/28/2026 | A · Award | +45.22K | — | — | 73.2% | 61.80K | 107.02K |
| Total | +45.22K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported